Joel Xue Yi Lim1, Min En Nga2, Dedrick Kok Hong Chan3, Wee Boon Tan4, Rajeev Parameswaran4, Kee Yuan Ngiam4. 1. 1 Yong Loo Lin School of Medicine, National University of Singapore , Singapore . 2. 2 Department of Pathology, National University of Singapore , Singapore . 3. 3 Department of General Surgery, National University of Singapore , Singapore . 4. 4 Division of Endocrine Surgery, National University of Singapore , Singapore .
Abstract
BACKGROUND: Although The Bethesda System for Reporting Thyroid Cytopathology has provided clinicians with a standardized classification scheme for the diagnosis of thyroid fine-needle aspiration cytology (FNAC) specimens, the indeterminate categories of Bethesda III (B3)-atypia of undetermined significance/follicular lesion of undetermined significance (AUS/FLUS)-and Bethesda IV (B4)-follicular neoplasm/suspicious for follicular neoplasm (FN/SFN)-continue to pose challenges with regards to ideal diagnostic and therapeutic management. Having previously demonstrated the presence of nuclear atypia as a high-risk subgroup in B3, the objective of this study was to evaluate the malignancy rates in the B4 subgroup with nuclear atypia. METHODS: A retrospective review of all thyroid FNACs diagnosed as B4 (FN/SFN) between 2008 and 2015 was conducted at a tertiary referral center in Singapore. Data on patient demographics, sonographic features, and final histological diagnosis were collected. This was compared to data from a previous analysis on all nodules diagnosed as B3 (AUS/FLUS) over a similar period. RESULTS: A total of 137/309 (44.3%) and 88/111 (79.3%) FNACs diagnosed as B3 and B4, respectively, underwent surgical excision yielding final histopathological diagnoses. The malignancy rate of B4 was 31/88 (35.2%) compared to B3, which was 37/137 (27.0%). Subclassification based on the presence of architectural versus nuclear atypia showed significantly higher malignancy rates in B4 nodules with nuclear atypia (21.8% vs. 57.6%; p < 0.01). These findings corroborate previous results within the B3 category (malignancy rate of 14.7% vs. 36.8%; p < 0.01). The only sonographic features predictive of malignancy were the presence of macrocalcifications in B4 compared to irregularity of margins in B3. CONCLUSION: The presence of nuclear atypia identifies subgroups with significant differential malignancy risks within both the B3 and B4 categories. This supports the notion that subclassification is a useful risk stratification tool that can guide diagnostic and therapeutic management of indeterminate thyroid nodules with heterogenous risk profiles.
BACKGROUND: Although The Bethesda System for Reporting Thyroid Cytopathology has provided clinicians with a standardized classification scheme for the diagnosis of thyroid fine-needle aspiration cytology (FNAC) specimens, the indeterminate categories of Bethesda III (B3)-atypia of undetermined significance/follicular lesion of undetermined significance (AUS/FLUS)-and Bethesda IV (B4)-follicular neoplasm/suspicious for follicular neoplasm (FN/SFN)-continue to pose challenges with regards to ideal diagnostic and therapeutic management. Having previously demonstrated the presence of nuclear atypia as a high-risk subgroup in B3, the objective of this study was to evaluate the malignancy rates in the B4 subgroup with nuclear atypia. METHODS: A retrospective review of all thyroid FNACs diagnosed as B4 (FN/SFN) between 2008 and 2015 was conducted at a tertiary referral center in Singapore. Data on patient demographics, sonographic features, and final histological diagnosis were collected. This was compared to data from a previous analysis on all nodules diagnosed as B3 (AUS/FLUS) over a similar period. RESULTS: A total of 137/309 (44.3%) and 88/111 (79.3%) FNACs diagnosed as B3 and B4, respectively, underwent surgical excision yielding final histopathological diagnoses. The malignancy rate of B4 was 31/88 (35.2%) compared to B3, which was 37/137 (27.0%). Subclassification based on the presence of architectural versus nuclear atypia showed significantly higher malignancy rates in B4 nodules with nuclear atypia (21.8% vs. 57.6%; p < 0.01). These findings corroborate previous results within the B3 category (malignancy rate of 14.7% vs. 36.8%; p < 0.01). The only sonographic features predictive of malignancy were the presence of macrocalcifications in B4 compared to irregularity of margins in B3. CONCLUSION: The presence of nuclear atypia identifies subgroups with significant differential malignancy risks within both the B3 and B4 categories. This supports the notion that subclassification is a useful risk stratification tool that can guide diagnostic and therapeutic management of indeterminate thyroid nodules with heterogenous risk profiles.
Entities:
Keywords:
Bethesda classification; atypia of undetermined significance (AUS)/follicular lesion of undetermined significance (FLUS); fine-needle aspiration cytology; follicular neoplasm (FN)/suspicious for follicular neoplasm (SFN); malignancy risk; thyroid
Authors: Miguel Paja; Jose Luis Del Cura; Rosa Zabala; Igone Korta; Aitziber Ugalde; José I López Journal: Eur Radiol Date: 2019-02-19 Impact factor: 5.315
Authors: Sunyoung Kang; Seul Ki Kwon; Hoon Sung Choi; Min Joo Kim; Young Joo Park; Do Joon Park; Sun Wook Cho Journal: Endocrinol Metab (Seoul) Date: 2021-10-21
Authors: Won Sang Yoo; Hwa Young Ahn; Hye Shin Ahn; Yun Jae Chung; Hee Sung Kim; Bo Youn Cho; Mirinae Seo; Jae Hoon Moon; Young Joo Park Journal: Medicine (Baltimore) Date: 2020-01 Impact factor: 1.817
Authors: Caroline Y Hayashi; Danilo T A Jaune; Cristiano C Oliveira; Bárbara P Coelho; Hélio A Miot; Mariângela E A Marques; José Vicente Tagliarini; Emanuel C Castilho; Carlos S P Soares; Flávia R K Oliveira; Paula Soares; Gláucia M F S Mazeto Journal: Endocr Connect Date: 2021-06-29 Impact factor: 3.335